Hidradenitis Suppurativa

 

This guideline applies to adults aged 18 years and over.

 

Management Optimisation:

• Address smoking and encourage weight loss if needed
   
• Screen for cardiovascular risk: Bloods (lipids, Hba1c, TFTs), BP
   
• Follow general management principles and treatment pathway as per PCDS Hidradenitis Suppurativa management.

 

Advice and Guidance

Please send advice and guidance requests via e-RS.

 

Referral

Referral criteria (routine or urgent depending on severity):

• Severe disease or scarring at initial presentation (refer straight away whilst initiating treatment)
   
• Patients where there has been an unsatisfactory response to long term oral antibiotics for consideration of biologic therapy (second-line options can be trialled whilst referring)
   
• For surgery for localised disease
   
• Pregnancy

 

Supporting Information

For professionals:

• DermNet – Hidradenitis suppurativa
• PCDS – Hidradenitis Suppurativa

For patients:

• British Association of Dermatology – Hidradenitis suppurativa

References

Ingram J, Collier F, Brown D et al. British Association of Dermatologists guidelines for the management of hidradenitis suppurativa (acne inversa) 2018. Br J Dermatol 2018; 180 (5): 1009–1017.

 

Page Review Information

Review date	24 October 2024
Next review date	24 October 2026
GP speciality lead	Dr Madeleine Attridge
Contributors	Dr Preshita Divekar, Consultant Dermatologist Dr Vandana Jones, Consultant Dermatologist Dr Alexander Anderson, Associate Specialist Dr Lisa Haddon, Consultant Dermatologist Dr Emma Porter ST4 Dermatology